Futures in Biotech 76
Recorded: February 25, 2011
Published: February 25, 2011
Futures in Biotech 76: It's Time To Proteo Me
How mass spectrometry has become one of the most important technologies in our move toward personalized medicine.
- Marc F. Pelletier, Ph.D., VP- Chief Scientific Officer, Aeromics, LLC; Adjunct Professor, Department of Physiology & Biophysics, Case Western Reserve University, Cleveland, OH
- Vincent Racaniello, Ph.D., Professor of Microbiology & Host of This Week in Virology, Host of This Week in Parasitism, Columbia University, New York, NY
- Dr. Rudolf Aebersold, Prof. Ruedi Aebersold, Institute of Molecular Systems Biology, Swiss Federal Institute of Technology & Professor in Faculty of Science, University of Zurich, Zurich, Switzerland
Prof. Ruedi Aebersold is one of the pioneers in the field of proteomics. He is known for developing a series of methods that have found wide application in analytical protein chemistry and proteomics like a new class of reagents termed Isotope Coded Affinity Tag (ICAT) reagents used in quantitative mass spectrometry. Prof. Dr. Aebersold and his team of researchers use the protein profiles determined by this method to differentiate cells in different states, such as noncancerous versus cancerous cells, and to systematically study how cells respond to external stimuli. These "snapshot" profiles indicate which cells contain abnormal levels of certain proteins. This is expected to lead to new diagnostic markers for disease and to a more complete understanding of the biochemical processes that control and constitute cell physiology.
Prof. Aebersold serves on the Scientific Advisory Committees of numerous academic and private sector research organizations and is a member of several editorial boards in the fields of protein science, genomics, and proteomics.
Prof. Aebersold is a native of Switzerland and obtained his Ph.D. in Cellular Biology at the Biocenter of the University of Basel in 1983. Since that time, he is a faculty member of the Universities of Washington and British Columbia, until 2000, when he co-founded the Institute for Systems Biology in Seattle. In 2004, he accepted a position as full professor at the Institute of Biotechnology at the Swiss Federal Institute of Technology (ETH) in Zurich, where in January 2005, his research group became the first integral part of the newly founded Institute of Molecular Systems Biology.
Synergy - Kaleidagraph
- ad times: :30 - :53 and 42:33 - 45:16
- Edited by:
|This area is for use by TWiT staff only. Please do not add or edit any content within this section.|